Vendor review
Licensed Peptides is graded B+ (80/100). It passed the trust floor (a score of at least 70 with testing, transparency and catalog data all observed), so its offers can be picks. We track 25 offers from Licensed Peptides. Prices last checked Nov 14, 2026.
Prices checked · Picks as of · Grade evidence cutoff
Price position
Cheaper than the median on 3 of 22 products that other tracked vendors also sell; above it on 18 and at it on 1. 3 other products have no other tracked offer. Prices are effective single-package prices; the median covers every tracked offer for the same product.
| Product | Licensed Peptides price | Median of tracked offers | Position | Pick |
|---|---|---|---|---|
| BPC-157 10 mg vial 10-pack | $399.99out of stock when checked | $4005 offers | Just below the median | |
| BPC-157 10 mg vial 2-pack | $99.99out of stock when checked | None1 offer | Only tracked offer | |
| BPC-157 10 mg vial 4-pack | $199.98out of stock when checked | None1 offer | Only tracked offer | |
| BPC-157 5 mg vial 10-pack | $337.50out of stock when checked | None1 offer | Only tracked offer | |
| CJC-1295/Ipamorelin Blend 10 mg vial 10-pack | $539.95out of stock when checked | $4503 offers | 20% above the median | |
| GHK-Cu 100 mg vial 10-pack | $674.95out of stock when checked | $3556 offers | 90% above the median | |
| GHK-Cu 50 mg vial 10-pack | $359.95out of stock when checked | $359.955 offers | At the median | |
| GLOW Blend (GHK-Cu/BPC-157/TB-500) 70 mg vial 10-pack | $989.95out of stock when checked | $6954 offers | 42% above the median | |
| Ipamorelin 10 mg vial 10-pack | $404.95out of stock when checked | $367.484 offers | 10% above the median | |
| KLOW Blend (GHK-Cu/BPC-157/TB-500/KPV) 80 mg vial 10-pack | $1,075out of stock when checked | $7005 offers | 54% above the median | |
| KPV 10 mg vial 10-pack | $449.95out of stock when checked | $313.504 offers | 44% above the median | |
| MOTS-c 10 mg vial 10-pack | $449.96out of stock when checked | $424.995 offers | 6% above the median | |
| NAD+ 500 mg vial 10-pack | $742.45out of stock when checked | $372.506 offers | 99% above the median | |
| PT-141 (Bremelanotide) 10 mg vial 10-pack | $517.45out of stock when checked | $2353 offers | 120% above the median | |
| Retatrutide 10 mg vial 10-pack | $674.95out of stock when checked | $4654 offers | 45% above the median | |
| Retatrutide 20 mg vial 10-pack | $989.95out of stock when checked | $6623 offers | 50% above the median | |
| Retatrutide 30 mg vial 10-pack | $1,214.95out of stock when checked | $1,056.982 offers | 15% above the median | |
| Retatrutide 5 mg vial 10-pack | $359.95out of stock when checked | $239.482 offers | 50% above the median | |
| TB-500 10 mg vial 10-pack | $584.95out of stock when checked | $611.474 offers | 4% below the median | |
| Tesamorelin 10 mg vial 10-pack | $764.95out of stock when checked | $547.506 offers | 40% above the median | |
| Tesamorelin/Ipamorelin Blend 10 mg vial 10-pack | $899.95out of stock when checked | $699.982 offers | 29% above the median | |
| Tirzepatide 10 mg vial 10-pack | $359.95out of stock when checked | $404.976 offers | 11% below the median | |
| Tirzepatide 20 mg vial 10-pack | $674.95out of stock when checked | $552.482 offers | 22% above the median | |
| Tirzepatide 30 mg vial 10-pack | $854.95out of stock when checked | $752.476 offers | 14% above the median | |
| Tirzepatide 60 mg vial 10-pack | $2,618.90out of stock when checked | $9233 offers | 184% above the median |
Picks won
No picks as of Nov 14, 2026: none of its offers met every pick rule.
Testing record
Of 25 tracked products: 1 with a lab-verified COA, 16 with a product COA on file and 8 with only COAs for other products. 455 public COAs from Licensed Peptides are archived; the newest was tested Aug 28, 2026. Labs named on COAs for its tracked products: Janoshik Analytical and Vanguard Laboratory.
A COA describes the batch it names. It does not show which lot a vendor ships today, and PepGrades does not ask vendors to say.
Deals
No automatic deal from Licensed Peptides is on record.
Transparency checklist
6 of 8 public pages were found when the grade was built (evidence cutoff Sep 12, 2026). A page found is not a review of its terms; shipping fees, delivery times and refund terms are not recorded.
Grade
B+ (80/100) from the components below, with evidence up to Sep 12, 2026. Price updates do not change the grade; public discussion is not scored.